Outsourcing in Clinical Trials East Asia 2018

5 December - 6 December, 2018

pauladams@arena-international.com

+44 (0)20 7936 6948

http://www.arena-international.com/octeastasia/

Intercontinental Seoul Coex, South Korea

Event Type:

Organized By:

Arena International

production@arena-international.com

http://www.arena-international.com

About Outsourcing in Clinical Trials East Asia 2018

Arena International is excited to announce that the 4th Outsourcing in Clinical Trial East Asia conference is returning to Seoul, 5th – 6th December 2018 with tailored topics to local trial sponsors.

This conference addresses how companies can effectively planning Multiregional Clinical Trials in light of changing regulations in East Asia region and sourcing local/global vendors according to study purpose and be responsive to industry trends to enable early market penetration.

This conference offers great opportunity for delegates to network with industry professionals and service providers, as well as attending insightful lectures from experienced clinicians in East Asia area.

Speakers

Speaker

More...

Visitors Profile

The key aim of the event is to offer case studies and insight into how to effectively outsource and conduct global trials with reducing budget throughout East Asia. The programme incorporates insight from both small and big pharma and sessions will take place in both English and Korean.

Event Partners

pharma licensing

pharma journalist

Bentham Science

pharmatutor

Drug Developement technology

More...

Post/Register Your Event

Quick Links

Media Pack Download

Newsletters

Event Location Map

Intercontinental Seoul Coex, South Korea

Organizer Testimonials

<p>I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.</p>

Baoping Wang

Novo Nordisk (China) R&D Centre

<p>Working with Ochre has been one of the most rewarding experiences of my career. Their attention to detail, innovative approach, and unwavering commitment to excellence set them apart from others in the pharma industry. They are a professional media information platform recognized by the industry. I am confident that anyone who chooses to collaborate with them will be equally impressed. Thanks for making such a positive impact on CPHI & PMEC China.</p>